Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 1 | — | — | — | 1 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 1 | 1 | — | — | — | 1 |
Drug common name | MAVELERTINIB |
INN | mavelertinib |
Description | Mavelertinib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target epidermal growth factor receptor. |
Classification | Small molecule |
Drug class | tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3ncn(C)c3n2)C[C@H]1F |
PDB | — |
CAS-ID | 1776112-90-3 |
RxCUI | — |
ChEMBL ID | CHEMBL3989970 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | YXX2180047 (ChemIDplus, GSRS) |